GERON CORP Inventory, Raw Materials, Net of Reserves
GERON CORP (GERN) had Inventory, Raw Materials, Net of Reserves of $7.96 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative
us-gaap:InventoryRawMaterialsNetOfReserves · last filed 2026-08-05
- 2026-06-30: Inventory, Raw Materials, Net of Reserves $7.96M.
- 2026-03-31: Inventory, Raw Materials, Net of Reserves $15.60M.
- 2025-12-31: Inventory, Raw Materials, Net of Reserves $8.93M.
- 2025-09-30: Inventory, Raw Materials, Net of Reserves $13.86M.
| Period end | Inventory, Raw Materials, Net of Reserves |
|---|---|
| 2026-06-30 | $7.96M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $15.60M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $8.93M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $13.86M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $7.58M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $7.38M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $4.90M 10-K · filed 2026-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |